202 related articles for article (PubMed ID: 18283864)
21. Tissue donation and virus safety: more nucleic acid amplification testing is needed.
Pruss A; Caspari G; Krüger DH; Blümel J; Nübling CM; Gürtler L; Gerlich WH
Transpl Infect Dis; 2010 Oct; 12(5):375-86. PubMed ID: 20412535
[TBL] [Abstract][Full Text] [Related]
22. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
23. Transfusion-transmissible infections.
Vrielink H; Reesink HW
Curr Opin Hematol; 1998 Nov; 5(6):396-405. PubMed ID: 9814646
[TBL] [Abstract][Full Text] [Related]
24. [Emerging infectious disease and transfusion-transmitted infection].
Yonemura Y
Rinsho Ketsueki; 2021; 62(8):1296-1301. PubMed ID: 34497219
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B, hepatitis C and HIV transfusion-transmitted infections in the 21st century.
Dwyre DM; Fernando LP; Holland PV
Vox Sang; 2011 Jan; 100(1):92-8. PubMed ID: 21175659
[TBL] [Abstract][Full Text] [Related]
26. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
Shang G; Seed CR; Wang F; Nie D; Farrugia A
Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
[TBL] [Abstract][Full Text] [Related]
27. Transfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India.
Shyamala V
Transfus Med; 2014 Apr; 24(2):79-88. PubMed ID: 24605952
[TBL] [Abstract][Full Text] [Related]
28. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
29. Trends in major transfusion-transmissible infections among blood donors over 17 years in Istanbul, Turkey.
Kocak N; Hepgul S; Ozbayburtlu S; Altunay H; Ozsoy MF; Kosan E; Aksu Y; Yilmaz G; Pahsa A
J Int Med Res; 2004; 32(6):671-5. PubMed ID: 15587762
[TBL] [Abstract][Full Text] [Related]
30. [Risk of transfusional-transmitted infections].
Blejer JL; Carreras Vescio LA; Salamone HJ
Medicina (B Aires); 2002; 62(3):259-78. PubMed ID: 12150011
[TBL] [Abstract][Full Text] [Related]
31. Transfusion-transmitted diseases. Current status and future directions.
DePalma L
J Int Fed Clin Chem; 1994 Sep; 6(4):131-5. PubMed ID: 10155144
[TBL] [Abstract][Full Text] [Related]
32. Risks of blood transfusion.
Goodnough LT
Crit Care Med; 2003 Dec; 31(12 Suppl):S678-86. PubMed ID: 14724466
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
Aggarwal V; Prakash C; Yadav S; Chattopadhya D
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
[TBL] [Abstract][Full Text] [Related]
34. Transfusion-transmitted hepatitis B virus infection.
Candotti D; Allain JP
J Hepatol; 2009 Oct; 51(4):798-809. PubMed ID: 19615780
[TBL] [Abstract][Full Text] [Related]
35. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing.
Jarvis LM; Dow BC; Cleland A; Davidson F; Lycett C; Morris K; Webb B; Jordan A; Petrik J
Vox Sang; 2005 Oct; 89(3):128-34. PubMed ID: 16146504
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.
Offergeld R; Faensen D; Ritter S; Hamouda O
Euro Surveill; 2005 Feb; 10(2):8-11. PubMed ID: 15735310
[TBL] [Abstract][Full Text] [Related]
37. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
38. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors.
Tafesse TB; Gebru AA; Gobalee S; Belay GD; Belew MT; Ataro D; Ebrahim BA; Shebeshi GM; Yimam Y
Hum Antibodies; 2017; 25(1-2):39-55. PubMed ID: 28009328
[TBL] [Abstract][Full Text] [Related]
39. [Do we need autologous blood donation?].
Schved JF
Ann Fr Anesth Reanim; 2004 May; 23(5):468-73. PubMed ID: 15158237
[TBL] [Abstract][Full Text] [Related]
40. West Nile virus blood transfusion-related infection despite nucleic acid testing.
Macedo de Oliveira A; Beecham BD; Montgomery SP; Lanciotti RS; Linnen JM; Giachetti C; Pietrelli LA; Stramer SL; Safranek TJ
Transfusion; 2004 Dec; 44(12):1695-9. PubMed ID: 15584982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
